Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NRIX |
---|---|---|
09:32 ET | 2441 | 23.55 |
09:36 ET | 197 | 23.2 |
09:38 ET | 600 | 23.39 |
09:43 ET | 1215 | 23.204 |
09:45 ET | 400 | 23.34 |
09:50 ET | 3522 | 23.47 |
09:52 ET | 3400 | 23.46 |
09:54 ET | 4100 | 23.3 |
09:56 ET | 100 | 23.41 |
09:59 ET | 400 | 23.405 |
10:01 ET | 976 | 23.47 |
10:06 ET | 100 | 23.395 |
10:08 ET | 334 | 23.33 |
10:10 ET | 100 | 23.37 |
10:12 ET | 816 | 23.39 |
10:14 ET | 2756 | 23.35 |
10:15 ET | 100 | 23.29 |
10:17 ET | 100 | 23.34 |
10:19 ET | 100 | 23.39 |
10:21 ET | 1200 | 23.39 |
10:24 ET | 1200 | 23.41 |
10:26 ET | 800 | 23.345 |
10:28 ET | 400 | 23.28 |
10:30 ET | 650 | 23.325 |
10:32 ET | 700 | 23.41 |
10:33 ET | 700 | 23.32 |
10:35 ET | 400 | 23.24 |
10:37 ET | 548 | 23.25 |
10:39 ET | 600 | 23.33 |
10:42 ET | 400 | 23.34 |
10:44 ET | 100 | 23.32 |
10:46 ET | 100 | 23.33 |
10:48 ET | 1381 | 23.4 |
10:51 ET | 300 | 23.42 |
10:55 ET | 300 | 23.35 |
11:02 ET | 400 | 23.28 |
11:04 ET | 300 | 23.2 |
11:06 ET | 645 | 23.235 |
11:08 ET | 500 | 23.32 |
11:09 ET | 300 | 23.325 |
11:11 ET | 100 | 23.29 |
11:15 ET | 100 | 23.33 |
11:18 ET | 1495 | 23.39 |
11:20 ET | 200 | 23.35 |
11:22 ET | 300 | 23.305 |
11:27 ET | 400 | 23.18 |
11:31 ET | 1507 | 23.26 |
11:33 ET | 100 | 23.22 |
11:36 ET | 200 | 23.27 |
11:38 ET | 100 | 23.24 |
11:40 ET | 500 | 23.215 |
11:44 ET | 500 | 23.305 |
11:47 ET | 400 | 23.305 |
11:49 ET | 200 | 23.31 |
11:51 ET | 300 | 23.29 |
11:58 ET | 100 | 23.34 |
12:00 ET | 100 | 23.28 |
12:03 ET | 300 | 23.31 |
12:05 ET | 100 | 23.31 |
12:07 ET | 300 | 23.29 |
12:09 ET | 500 | 23.4 |
12:16 ET | 800 | 23.3 |
12:18 ET | 100 | 23.27 |
12:21 ET | 626 | 23.24 |
12:25 ET | 100 | 23.2 |
12:27 ET | 100 | 23.22 |
12:30 ET | 300 | 23.25 |
12:32 ET | 300 | 23.2 |
12:36 ET | 1128 | 23.23 |
12:38 ET | 100 | 23.26 |
12:39 ET | 200 | 23.27 |
12:41 ET | 100 | 23.27 |
12:43 ET | 882 | 23.26 |
12:48 ET | 500 | 23.28 |
12:50 ET | 100 | 23.3 |
12:52 ET | 100 | 23.295 |
12:57 ET | 558 | 23.34 |
12:59 ET | 4534 | 23.42 |
01:01 ET | 1090 | 23.375 |
01:03 ET | 300 | 23.4 |
01:08 ET | 100 | 23.38 |
01:10 ET | 700 | 23.35 |
01:12 ET | 200 | 23.31 |
01:14 ET | 100 | 23.32 |
01:15 ET | 100 | 23.36 |
01:17 ET | 588 | 23.34 |
01:24 ET | 100 | 23.39 |
01:26 ET | 800 | 23.41 |
01:28 ET | 200 | 23.41 |
01:30 ET | 300 | 23.5 |
01:32 ET | 200 | 23.43 |
01:33 ET | 700 | 23.49 |
01:37 ET | 245 | 23.47 |
01:39 ET | 200 | 23.4 |
01:42 ET | 100 | 23.42 |
01:44 ET | 986 | 23.4015 |
01:46 ET | 100 | 23.39 |
01:48 ET | 100 | 23.45 |
01:50 ET | 413 | 23.46 |
01:57 ET | 100 | 23.49 |
02:00 ET | 525 | 23.44 |
02:02 ET | 100 | 23.42 |
02:04 ET | 250 | 23.41 |
02:06 ET | 400 | 23.4 |
02:09 ET | 728 | 23.3 |
02:11 ET | 200 | 23.33 |
02:13 ET | 500 | 23.36 |
02:18 ET | 100 | 23.34 |
02:20 ET | 300 | 23.335 |
02:22 ET | 100 | 23.31 |
02:24 ET | 100 | 23.315 |
02:31 ET | 300 | 23.18 |
02:33 ET | 1700 | 23.175 |
02:38 ET | 500 | 23.1 |
02:40 ET | 372 | 23.1 |
02:42 ET | 400 | 23.08 |
02:44 ET | 200 | 23.12 |
02:45 ET | 200 | 23.16 |
02:47 ET | 200 | 23.18 |
02:49 ET | 100 | 23.195 |
02:54 ET | 200 | 23.19 |
02:56 ET | 136 | 23.19 |
03:00 ET | 100 | 23.23 |
03:03 ET | 415 | 23.15 |
03:05 ET | 200 | 23.1425 |
03:07 ET | 500 | 23.15 |
03:09 ET | 327 | 23.18 |
03:12 ET | 100 | 23.15 |
03:16 ET | 300 | 23.16 |
03:20 ET | 408 | 23.07 |
03:21 ET | 100 | 23.05 |
03:23 ET | 400 | 23.11 |
03:27 ET | 200 | 23.13 |
03:30 ET | 100 | 23.115 |
03:32 ET | 200 | 23.09 |
03:34 ET | 1000 | 23.14 |
03:36 ET | 300 | 23.145 |
03:38 ET | 438 | 23.135 |
03:39 ET | 1482 | 23.1 |
03:41 ET | 589 | 23.115 |
03:43 ET | 600 | 23.1 |
03:48 ET | 236 | 23.1 |
03:50 ET | 700 | 23.115 |
03:52 ET | 1700 | 23.08 |
03:54 ET | 1282 | 23.04 |
03:56 ET | 1772 | 23.09 |
03:57 ET | 300 | 23.095 |
03:59 ET | 46886 | 23.04 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nurix Therapeutics Inc | 1.6B | -7.9x | --- |
Arvinas Inc | 1.7B | -4.7x | --- |
Immatics NV | 1.3B | -12.6x | --- |
Arcus Biosciences Inc | 1.5B | -5.0x | --- |
Ardelyx Inc | 1.5B | -23.9x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.3x | --- |
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $62.3M |
Shares Outstanding | 64.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $-2.92 |
Book Value | $4.12 |
P/E Ratio | -7.9x |
Price/Sales (TTM) | 25.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -287.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.